Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis - Laila M. Rad; Kevin R. Hughes; Sydney N. Wheeler; Joseph T. Decker; Sophia M. Orbach; Angelica Galvan; Jasmine Thornhill; Kate V. Griffin; Hamza Turkistani; Russell R. Urie; David N. Irani; Lonnie D. Shea; et al. (Proceedings of the National Academy of Sciences, 2025)